| Protein | Synonyms | Taxonomy |
|---|
| Aspartate aminotransferase, mitochondrial | mAspAT; EC 2.6.1.1; EC 2.6.1.7; Fatty acid-binding protein; FABP-1; Glutamate oxaloacetate transaminase 2; Kynurenine aminotransferase 4; Kynurenine aminotransferase IV; Kynurenine--oxoglutarate transaminase 4; Kynurenine--oxoglutarate transaminase IV; Pl | Homo sapiens (human) |
| Glutaminase liver isoform, mitochondrial | GLS; EC 3.5.1.2; L-glutaminase; L-glutamine amidohydrolase | Homo sapiens (human) |
| Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial | P5C dehydrogenase; EC 1.2.1.88; Aldehyde dehydrogenase family 4 member A1; L-glutamate gamma-semialdehyde dehydrogenase | Homo sapiens (human) |
| Nitric oxide synthase, inducible | EC 1.14.13.39; Hepatocyte NOS; HEP-NOS; Inducible NO synthase; Inducible NOS; iNOS; NOS type II; Peptidyl-cysteine S-nitrosylase NOS2 | Homo sapiens (human) |
| Alanine aminotransferase 1 | ALT1; EC 2.6.1.2; Glutamate pyruvate transaminase 1; GPT 1; Glutamic--alanine transaminase 1; Glutamic--pyruvic transaminase 1 | Homo sapiens (human) |
| Nitric oxide synthase, brain | EC 1.14.13.39; Constitutive NOS; NC-NOS; NOS type I; Neuronal NOS; N-NOS; nNOS; Peptidyl-cysteine S-nitrosylase NOS1; bNOS | Homo sapiens (human) |
| Pyrroline-5-carboxylate reductase 1, mitochondrial | P5C reductase 1; P5CR 1; EC 1.5.1.2 | Homo sapiens (human) |
| Ornithine aminotransferase, mitochondrial | EC 2.6.1.13; Ornithine delta-aminotransferase; Ornithine--oxo-acid aminotransferase | Homo sapiens (human) |
| L-lactate dehydrogenase B chain | LDH-B; EC 1.1.1.27; LDH heart subunit; LDH-H; Renal carcinoma antigen NY-REN-46 | Homo sapiens (human) |
| Aspartate aminotransferase, cytoplasmic | cAspAT; EC 2.6.1.1; EC 2.6.1.3; Cysteine aminotransferase, cytoplasmic; Cysteine transaminase, cytoplasmic; cCAT; Glutamate oxaloacetate transaminase 1; Transaminase A | Homo sapiens (human) |
| Carbamoyl-phosphate synthase [ammonia], mitochondrial | EC 6.3.4.16; Carbamoyl-phosphate synthetase I; CPSase I | Homo sapiens (human) |
| Arginase-1 | EC 3.5.3.1; Liver-type arginase; Type I arginase | Homo sapiens (human) |
| Nitric oxide synthase, endothelial | EC 1.14.13.39; Constitutive NOS; cNOS; EC-NOS; Endothelial NOS; eNOS; NOS type III; NOSIII | Homo sapiens (human) |
| Malate dehydrogenase, mitochondrial | EC 1.1.1.37 | Homo sapiens (human) |
| Ornithine transcarbamylase, mitochondrial | OTCase; EC 2.1.3.3; Ornithine carbamoyltransferase, mitochondrial | Homo sapiens (human) |
| Malate dehydrogenase, cytoplasmic | EC 1.1.1.37; Cytosolic malate dehydrogenase; Diiodophenylpyruvate reductase; 1.1.1.96 | Homo sapiens (human) |
| Calcium-binding mitochondrial carrier protein Aralar2 | Citrin; Mitochondrial aspartate glutamate carrier 2; Solute carrier family 25 member 13 | Homo sapiens (human) |
| Argininosuccinate synthase | EC 6.3.4.5; Citrulline--aspartate ligase | Homo sapiens (human) |
| N-acetylglutamate synthase, mitochondrial | EC 2.3.1.1; Amino-acid acetyltransferase | Homo sapiens (human) |
| Glutamate dehydrogenase 1, mitochondrial | GDH 1; EC 1.4.1.3 | Homo sapiens (human) |
| Calcium-binding mitochondrial carrier protein Aralar1 | Mitochondrial aspartate glutamate carrier 1; Solute carrier family 25 member 12 | Homo sapiens (human) |
| Argininosuccinate lyase | ASAL; EC 4.3.2.1; Arginosuccinase | Homo sapiens (human) |
| Fumarate hydratase, mitochondrial | Fumarase; HsFH; EC 4.2.1.2 | Homo sapiens (human) |
| Mitochondrial ornithine transporter 1 | Solute carrier family 25 member 15 | Homo sapiens (human) |
| Compound | Description |
|---|
| urea | A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. |
| Nitric Oxide | A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. |
| Arginine | An essential amino acid that is physiologically active in the L-form. |
| Ammonium | |
| Aspartate | |
| fumarates | Compounds based on fumaric acid. |
| uridine | A ribonucleoside in which RIBOSE is linked to URACIL. |
| hydrogen carbonate | |
| Pyruvic Acid | An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed) |
| uracil | One of four nucleotide bases in the nucleic acid RNA. |
| delta-1-pyrroline-5-carboxylate | (L)-isomer is the biologically active form; RN given refers to cpd without isomeric designation; structure |
| alpha-Ketoglutarate | |
| Oxaloacetate | An anionic form of oxaloacetic acid. |
| Carbamyl Phosphate | The monoanhydride of carbamic acid with PHOSPHORIC ACID. It is an important intermediate metabolite and is synthesized enzymatically by CARBAMYL-PHOSPHATE SYNTHASE (AMMONIA) and CARBAMOYL-PHOSPHATE SYNTHASE (GLUTAMINE-HYDROLYZING). |
| glutamate | |
| polyglutamine | RN given for (D)-isomer |
| Uridine Monophosphate | 5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. |
| Acetyl Coenzyme A | Acetyl CoA participates in the biosynthesis of fatty acids and sterols, in the oxidation of fatty acids and in the metabolism of many amino acids. It also acts as a biological acetylating agent. |
| orotidylic acid | structure |
| orotidine | RN given refers to parent cpd; structure |